Curr cancer drug targets 影响因子

WebCurr Cancer Drug Targets. 2024;19(9):688-697. doi: 10.2174/1568009619666190326123945. Authors ... testing prior to prescribing targeted therapy is crucial in identifying who can receive clinical benefit from specific cancer drugs. Over the last two decades, gastrointestinal stromal tumors (GISTs) have evolved from … WebCURRENT CANCER DRUG TARGETS. 出版年份：2001 年文章数：29 投稿命中率：43.75%. 出版周期：Monthly 自引率：1.2% 审稿周期：平均2.4月. 前往期刊查询. 期刊讨论 中国SCI论文 期刊主页 投稿经验 杂志官网 投稿链接 作者需知 PMC链接 Pubmed全文检索. 期刊论坛. 期刊 ...

Rediscovering Potential Molecular Targets for Glioma Therapy ... - PubMed

WebPubMed Central (PMC)链接：PubMed Central 平均审稿速度：网友分享经验：平均1月 平均录用比例：网友分享经验：约50% 在线出版周期： WebSep 15, 2024 · Current Cancer Drug Targets在中科院分区中属于 大类学科 医学4区 ，在小类学科属于 肿瘤学 4区 。 在JCR分区中，该期刊属于 Q3 区，在242本肿瘤学期刊中 … highland climate region https://stephanesartorius.com

Small molecules in targeted cancer therapy: advances

WebBentham Science Publishers. Bentham Science is a science, technology, and medical publisher, providing academic researchers and industrial professionals with the latest … Anti-Cancer Agents in Medicinal Chemistry ISSN (Print):1871-5206 ISSN … Articles By Disease - Welcome to Bentham Science Publisher Reprints are customized, reproductions of articles printed on high-quality paper for … Online Manuscript Submission and Tracking System: The Manuscript Processing … By Subject - Welcome to Bentham Science Publisher Recent Patents on Anti-Cancer Drug Discovery. ISSN: 2212-3970 (Online) … Anti-Cancer Agents in Medicinal Chemistry ISSN (Print):1871-5206 ISSN … Recent Patents on Anti-Cancer Drug Discovery . Impact Factor: 3.038 5-Year … Journal Catalog 2024. Catalog Description: Bentham Science Publishers’ 2024 … Web介绍. Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics … WebCurrent Drug Targets publishes guest edited thematic issues written by leaders in the field covering a range of current topics of drug targets. The journal also accepts for publication full-length/mini review articles and drug clinical trial studies. As the discovery, identification, characterization and validation of novel human drug targets ... highland clearances art

Promising Targets in Anti-cancer Drug Development: Recent Updates

Category:JOURNAL OF DRUG TARGETING_影响因子(IF)_中科院分区_SCI期刊 …

Tags:Curr cancer drug targets 影响因子

Curr cancer drug targets 影响因子

CURRENT CANCER DRUG TARGETS-期刊介绍-MedSci.cn

WebPubMed Central (PMC)链接：PubMed Central 平均审稿速度：网友分享经验：一般,3-8周 平均录用比例：网友分享经验：较难 在线出版周期： WebCurrent Cancer Drug Targets(当前的抗癌药物靶点)创刊于2001年，由BENTHAM SCIENCE PUBL LTD出版商出版，收稿方向涵盖医学 - 肿瘤学全领域，此期刊水平偏中 …

Curr cancer drug targets 影响因子

Did you know?

WebCurrent Cancer Drug Targets. ISSN (Print): 1568-0096. ISSN (Online): 1873-5576. Volume 23 , Issues 11, 2024. This journal supports open access. WebAug 15, 2024 · BTC is a rare and aggressive cancer disease, bearing an overall dismal prognosis with only finite therapy options. Only combination chemotherapy regimens achieve disease control, which is often only short-lived since the tumor tissue exhibits high resistance to chemotherapy. ... Curr Cancer Drug Targets. 2024 Aug 15;22(8):639-650. …

Web《current cancer drug targets》发布于爱科学网，并永久归类相关sci期刊导航类别中，本站只是硬性分析 "《curr cancer drug tar》" 杂志的可信度。学术期刊真正的价值在于它 … WebThis journal is devoted to timely reviews of experimental and clinical studies in the field of endocrine, metabolic, and immune disorders. Specific emphasis is placed on humoral and cellular targets for natural, synthetic, and genetically engineered drugs that enhance or impair endocrine, metabolic, and immune parameters and functions.

WebTargeting the ubiquitin-proteasome pathway has emerged as a rational approach in the treatment of human cancer. Based on positive preclinical and clinical studies, bortezomib was subsequently approved for the clinical use as a front-line treatment for newly diagnosed multiple myeloma patients and for the treatment of relapsed/refractory multiple myeloma … WebCURRENT CANCER DRUG TARGETS. 出版年份：2001 年文章数：29 投稿命中率：43.75%. 出版周期：Monthly 自引率：1.2% 审稿周期：平均2.4月. 前往期刊查询. 期刊 …

Web影响因子 IF 热搜. 2 ... Biomimetics Cell Stem Cell Pharmaceutical Biology PPAR Research Pharmacogenetics and Genomics Archives of Pharmacal Research Current Cancer Drug Targets Pharmacogenomics Journal EXCLI Journal Journal of Pharmacological Sciences MedChemComm Phytochemical Analysis Molecular Imaging Molecular ... pre-clinical …

WebApr 8, 2024 · 《journal of drug targeting》发布于爱科学网，并永久归类相关sci期刊导航类别中，本站只是硬性分析 "《j drug target》" 杂志的可信度。学术期刊真正的价值在于 … how is bounce rate measuredWeb期刊名称. CURR PROB CANCER/CURRENT PROBLEMS IN CANCER. ISSN. 0147-0272. 影响指数话题. 影响指数话题. 预警等级. MedSci期刊指数. 6.769 （MedSci实时期刊指数） 5.25578 （5年期刊指数）. highland clearances facts for kidsWebCurr Cancer Drug Targets. 2013 Jan;13(1):30-47. Authors ... Other drugs to consider are thalidomide, lenalidomide, antiangiogenic agents, tyrosine kinase inhibitors and heat shock protein 90 inhibitors, which all have both antileukemic and immunomodulatory effects. Relatively few clinical studies are available for patients with this high-risk ... how is bourbon made in kentuckyWeb介绍. Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics … highland clevelandWebCurr Cancer Drug Targets. 2024;21(7):558-574. doi: 10.2174/1568009621666210504091722. ... The microenvironment of gliomas includes non-cancer cells such as immune cells, fibroblasts, and cells of blood vessels, as well as secreted molecules and the extracellular matrix, and all these components play a vital … highland climate characteristicsWebAbstract. Background: Multiple myeloma (MM) is a hematological cancer caused by a proliferation of clonal plasma cells, leading to anemia, renal failure, hypercalcemia and destructive bone lesions resulting in significant morbidity. The overall survival has significantly improved with the incorporation of immunomodulatory drugs (IMiDs) and ... how is bounce rate calculatedWebCurrent Oncology is an international, peer-reviewed , open access journal published online by MDPI (from Volume 28 Issue 1-2024). The journal changes publication frequency from bimonthly to monthly in 2024. Established in 1994, the journal represents a multidisciplinary medium for clinical oncologists to report and review progress in the ... highland clearances sutherland